|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 3733712 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20180938.1 |
| Date of filing the European patent application | 2017-08-11 | |
| (97) | Date of publication of the European application | 2020-11-04 |
| (45) | Date of publication and mention of the grant of the patent | 2023-05-24 |
| (46) | Date of publication of the claims translation | 2023-09-11 |
| (30) | Number | Date | Country code |
| 201662374986 P | 2016-08-15 | US |
| (72) |
WALLSTRÖM, Erik , CH
SAVELIEVA PRAZ, Marina , CH
KAKARIEKA WEISSKOPF, Algirdas Jonas , CH
KAHN, Joseph Michael , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Išsėtinės sklerozės gydymo schemos ir būdai, panaudojant ofatumumabą |
| REGIMENS AND METHODS OF TREATING MULTIPLE SCLEROSIS USING OFATUMUMAB |
| Payment date | Validity (years) | Amount | |
| 2024-07-18 | 8 | 185.00 EUR |
| 2025-08-11 |